The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease.
Rennard SI, Fogarty C, Kelsen S, Long W, Ramsdell J, Allison J, Mahler D, Saadeh C, Siler T, Snell P, Korenblat P, Smith W, Kaye M, Mandel M, Andrews C, Prabhu R, Donohue JF, Watt R, Lo KH, Schlenker-Herceg R, Barnathan ES, Murray J; COPD Investigators.
Am J Respir Crit Care Med. 2007 May 1;175(9):926-34. Epub 2007 Feb 8.PMID: 17290043 [PubMed - indexed for MEDLINE]Related articlesFree article